Powerock Pharma MATRIXYL 10 mg
Powerock Pharma ensures results and pure Matrixyl 10 mg, which supports structural regeneration by stimulating fibroblasts and collagen synthesis to restore elasticity and tissue density, effectively reducing signs of aging in laboratory studies.
MATRIXYL (PALMITOYL PENTAPEPTIDE-4) 10 mg
MATRIXYL (PALMITOYL PENTAPEPTIDE-4) is an advanced, high-purity chemical reagent, a synthetic peptide that stimulates the extracellular matrix. This compound was designed for effective research on tissue regeneration and aging processes. Its action in laboratory conditions relies on mimicking natural matrikines, which enables more effective stimulation of fibroblasts to produce collagen. This unique property makes Matrixyl widely used in research on skin density, elasticity, and protein structure reconstruction.
Matrixyl Powerock Pharma - Properties
Discover the potential laboratory properties of Matrixyl that can support research on collagen synthesis, wrinkle reduction, and tissue density.
Collagen Synthesis
Stimulates the production of collagen type I, III, and IV in tested tissue models.
Structure Regeneration
Supports extracellular matrix repair processes, crucial for the density of the tested material.
Anti-Aging Effect
Shows strong potential in reducing wrinkle depth and volume in studies.
Improved Hydration
Influences glycosaminoglycan synthesis, improving water retention in tissue structure.
Increased Elasticity
Supports research on restoring resilience and tension in laboratory models.
Precise Action
Targets specific fibroblast receptors without inducing inflammation.
High Purity
≥98% peptide purity confirmed by HPLC analysis for reliable results.
Research Quality
Manufactured according to GMP, HACCP, and ISO 13485 standards exclusively for research purposes.
How Matrixyl (Palmitoyl Pentapeptide-4) Works
- Mimicking Matrikines: Acts as a signal messenger, "informing" cells of the need for structural repair, which simulates rejuvenation processes in research models.
- Fibroblast Activation: Directly stimulates dermal cells to increase production of supporting proteins.
- Matrix Reconstruction: Increases synthesis of fibronectin and hyaluronic acid, resulting in tissue structure "filling" in studies.
- Tissue Safety: Unlike retinoids, it does not induce irritation or inflammatory reactions in in vitro studies.
- Long-term Restructuring: Supports research on permanent improvement of skin quality and thickness in dermatological models.
Why Choose Matrixyl from Powerock Pharma?
At Powerock Pharma, our priority is to provide only the highest quality research reagents. Every batch of Matrixyl is manufactured in facilities complying with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of state-of-the-art testing procedures ensure not only product efficacy but also their chemical safety and reliability. Collaboration with leading laboratories to ensure purity ≥98% (HPLC) and substance effectiveness ensures durable and reproducible research results. By choosing Powerock Pharma, you opt for excellence, procedural safety, and unmatched quality of research materials.
Research Protocol
How to Research:
Matrixyl (lyophilized) requires reconstitution (e.g., bacteriostatic water). The substance is intended for application on a research medium (e.g., tissue cultures). The product is not intended for consumption.
Application Frequency:
To obtain optimal consistency of research results, it is recommended to apply the solution at regular intervals (usually 1-2 times daily in the medium's diurnal cycle).
Cycle Duration:
A typical research cycle for Matrixyl is 8–12 weeks. This period allows for observation of the full collagen remodeling cycle and documentation of lasting structural effects.
Recommended Concentration for Model A (Standard):
In standard regenerative studies, it is recommended to prepare a solution with a concentration of 3% (appropriate dilution of 10 mg substance in the base).
Recommended Concentration for Model B (Intensive):
For Model B, requiring deep restructuring, a concentration of up to 8% is used. The dose (solution volume) can be modified according to study goals and parameters.
Monitoring:
Continuous monitoring of tissue parameters is essential. Changes in elasticity, hydration, and structure density should be recorded throughout the study period.
Frequently Asked Questions
- The standard research concentration ranges from 3% (Model A) to 8% (Model B) of active substance in the solution applied to the research material. The 10 mg vial serves to prepare the base solution.
- Yes, in studies, Matrixyl shows high synergy with GHK-Cu (regeneration), Argireline (tension relaxation), and hyaluronic acid, allowing for the study of complex repair effects.
- The substance is generally very well tolerated. In rare cases, at extremely high concentrations, a local hypersensitivity reaction may occur at the application site.
- Yes, studies indicate a high safety profile and no cytotoxicity even with long-term cell exposure to the peptide. Product exclusively for laboratory use (not for human use).
- Lyophilized product should be stored at 2–8°C. After reconstitution, the solution should be kept in a refrigerator and used within the solvent's stability period.
- Our products are manufactured in facilities meeting GMP, HACCP, and ISO 13485 standards. Each batch has ≥98% purity (HPLC) and undergoes rigorous validation for quality, ensuring reproducibility of results.
Calculator for measuring research doses
Tip: 1 MG = 1000 MCG
